Every day at Arvinas, we advance pioneering science to develop new, transformative treatments for patients with limited treatment options, or for whom existing treatments have not been effective.
Our values drive the work we do and the way we collaborate.
Unfortunately, it is hard to find anyone whose life is not touched by cancer or neurodegenerative disease. Our engagement with the patient community keeps us focused on our mission.
PROTAC technology was invented at Yale University in New Haven, CT by the leading pioneer in the field, and we've been here ever since. We are proud of our New Haven roots and are committed to its emerging biotech community.
We see expansive potential for our PROTAC platform and we work with partners to extend its utility and reach, both in human therapeutics and crop protection.